Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122862595 | 12286259 | 5 | F | 20160819 | 20160420 | 20160829 | PER | US-PFIZER INC-2016194973 | PFIZER | 71.00 | YR | M | Y | 77.00000 | KG | 20160829 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122862595 | 12286259 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, 2 WEEKS ON/1 WEEK OFF | N | 21938 | 50 | MG | CAPSULE, HARD | |||||||
122862595 | 12286259 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | N | 21938 | CAPSULE, HARD | ||||||||||
122862595 | 12286259 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
122862595 | 12286259 | 4 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
122862595 | 12286259 | 5 | C | OXYCODONE | OXYCODONE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
122862595 | 12286259 | 6 | C | ZOMETA | ZOLEDRONIC ACID | 1 | UNK | 0 | |||||||||||
122862595 | 12286259 | 7 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
122862595 | 12286259 | 8 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | UNK | 0 | |||||||||||
122862595 | 12286259 | 9 | C | VITAMIN C | ASCORBIC ACID | 1 | UNK | 0 | |||||||||||
122862595 | 12286259 | 10 | C | BETA GLUCAN | BETA GLUCAN | 1 | UNK | 0 | |||||||||||
122862595 | 12286259 | 11 | C | PROBIOTIC COMPLEX | 2 | UNK | 0 | ||||||||||||
122862595 | 12286259 | 12 | C | RESVERATROL | RESVERATROL | 1 | UNK | 0 | |||||||||||
122862595 | 12286259 | 13 | C | SENNATAB | 2 | UNK | 0 | TABLET | |||||||||||
122862595 | 12286259 | 14 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | UNK, AS NEEDED | 0 | |||||||||||
122862595 | 12286259 | 15 | C | MELATONIN | MELATONIN | 1 | UNK, AS NEEDED | 0 | |||||||||||
122862595 | 12286259 | 16 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
122862595 | 12286259 | 17 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122862595 | 12286259 | 1 | Bone cancer |
122862595 | 12286259 | 2 | Metastatic renal cell carcinoma |
122862595 | 12286259 | 14 | Constipation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122862595 | 12286259 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122862595 | 12286259 | Arthralgia | |
122862595 | 12286259 | Asthenia | |
122862595 | 12286259 | Back pain | |
122862595 | 12286259 | Balance disorder | |
122862595 | 12286259 | Constipation | |
122862595 | 12286259 | Decreased appetite | |
122862595 | 12286259 | Dehydration | |
122862595 | 12286259 | Disease progression | |
122862595 | 12286259 | Dysgeusia | |
122862595 | 12286259 | Dyspepsia | |
122862595 | 12286259 | Fatigue | |
122862595 | 12286259 | Gastric disorder | |
122862595 | 12286259 | Headache | |
122862595 | 12286259 | Insomnia | |
122862595 | 12286259 | Listless | |
122862595 | 12286259 | Metastatic renal cell carcinoma | |
122862595 | 12286259 | Musculoskeletal pain | |
122862595 | 12286259 | Nausea | |
122862595 | 12286259 | Vomiting | |
122862595 | 12286259 | Weight decreased | |
122862595 | 12286259 | Weight fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122862595 | 12286259 | 1 | 20160320 | 0 |